Details for New Drug Application (NDA): 088909
NDA 088909 describes BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira, and is included in three NDAs. It is available from six suppliers. Additional details are available on the BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.
The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 088909
| Tradename: | BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Applicant: | Abraxis Pharm |
| Ingredient: | sodium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INJECTION | Strength | 270MG/30ML (9MG/ML) | ||||
| Approval Date: | Feb 7, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INJECTION | Strength | 90MG/10ML (9MG/ML) | ||||
| Approval Date: | May 15, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
